Filtering by:
Oral Cavity and Oropharyngeal CancerFDA Approves Keytruda (Pembrolizumab) for Head and Neck Cancer
The US Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) as a first-line treatment for people with advanced head and neck cancer.
More Teens Getting HPV Vaccinations
The US Centers for Disease Control and Prevention (CDC) reports that almost half (49%) of teenagers have been fully vaccinated for human papillomavirus (HPV), an increase of 5 percentage points from 2016.
HPV Vaccination Rates Low Among Childhood Cancer Survivors
Despite the fact that the HPV vaccine is widely available and can help prevent forms of cancer caused by the virus, most young cancer survivors don’t get vaccinated.
HPV Vaccination Rates are Rising Among American Teens
The Centers for Disease Control and Prevention (CDC) is reporting that vaccination rates for human papilloma virus (HPV) are rising among teenagers in the US.
American Cancer Society: 2 HPV Shots Instead of 3 OK for Ages 9-14
The American Cancer Society is endorsing a recommendation from the Advisory Committee on Immunization Practices (ACIP) that says boys and girls who start receiving the human papilloma virus (HPV) vaccine between ages 9 and 14 can get 2 doses instead of 3.